| Kaiser Foundation Health Plan Northern California |
| Kanjinti (trastuzumab-anns) |
| Drugs for Cancer : Drugs for Cancer |
- Prior Authorization: Narcolepsy Type 1, Narcolepsy Type 2:
Documented Diagnosis: Yes
Medical Test Required: Yes
Age Requirement: >= 7
Duration: 6 Month(s)
Reauthorization Required: Yes
Neurology: Narcolepsy:
PA Applies
|